Chou DK - Search Results

1

Effects of Tween 20 and Tween 80 on the stability of Albutropin during agitation.

Chou DK, Krishnamurthy R, Randolph TW, Carpenter JF, Manning MC. Chou DK, et al. J Pharm Sci. 2005 Jun;94(6):1368-81. doi: 10.1002/jps.20365. J Pharm Sci. 2005. PMID: 15858848

2

Effect of buffer species on the thermally induced aggregation of interferon-tau.

Katayama DS, Nayar R, Chou DK, Valente JJ, Cooper J, Henry CS, Vander Velde DG, Villarete L, Liu CP, Manning MC. Katayama DS, et al. Among authors: chou dk. J Pharm Sci. 2006 Jun;95(6):1212-26. doi: 10.1002/jps.20471. J Pharm Sci. 2006. PMID: 16637050

3

Physical stability of albinterferon-α(2b) in aqueous solution: effects of conformational stability and colloidal stability on aggregation.

Chou DK, Krishnamurthy R, Manning MC, Randolph TW, Carpenter JF. Chou DK, et al. J Pharm Sci. 2012 Aug;101(8):2702-19. doi: 10.1002/jps.23215. Epub 2012 Jun 6. J Pharm Sci. 2012. PMID: 22674119

4

Effects of solution conditions on methionine oxidation in albinterferon alfa-2b and the role of oxidation in its conformation and aggregation.

Chou DK, Krishnamurthy R, Manning MC, Randolph TW, Carpenter JF. Chou DK, et al. J Pharm Sci. 2013 Feb;102(2):660-73. doi: 10.1002/jps.23401. Epub 2012 Nov 30. J Pharm Sci. 2013. PMID: 23203978

5

Stability of protein pharmaceuticals: an update.

Manning MC, Chou DK, Murphy BM, Payne RW, Katayama DS. Manning MC, et al. Among authors: chou dk. Pharm Res. 2010 Apr;27(4):544-75. doi: 10.1007/s11095-009-0045-6. Epub 2010 Feb 9. Pharm Res. 2010. PMID: 20143256 Review.

6

Solution behavior of a novel type 1 interferon, interferon-tau.

Katayama DS, Nayar R, Chou DK, Campos J, Cooper J, Vander Velde DG, Villarete L, Liu CP, Cornell Manning M. Katayama DS, et al. Among authors: chou dk. J Pharm Sci. 2005 Dec;94(12):2703-15. doi: 10.1002/jps.20461. J Pharm Sci. 2005. PMID: 16258985

7

An industry perspective on the monitoring of subvisible particles as a quality attribute for protein therapeutics.

Singh SK, Afonina N, Awwad M, Bechtold-Peters K, Blue JT, Chou D, Cromwell M, Krause HJ, Mahler HC, Meyer BK, Narhi L, Nesta DP, Spitznagel T. Singh SK, et al. J Pharm Sci. 2010 Aug;99(8):3302-21. doi: 10.1002/jps.22097. J Pharm Sci. 2010. PMID: 20310025 Review.

8

Stress Factors in mAb Drug Substance Production Processes: Critical Assessment of Impact on Product Quality and Control Strategy.

Das TK, Narhi LO, Sreedhara A, Menzen T, Grapentin C, Chou DK, Antochshuk V, Filipe V. Das TK, et al. Among authors: chou dk. J Pharm Sci. 2020 Jan;109(1):116-133. doi: 10.1016/j.xphs.2019.09.023. Epub 2019 Oct 5. J Pharm Sci. 2020. PMID: 31593689 Review.

9

Emerging Challenges and Innovations in Surfactant-mediated Stabilization of Biologic Formulations.

Katz JS, Chou DK, Christian TR, Das TK, Patel M, Singh SN, Wen Y. Katz JS, et al. Among authors: chou dk. J Pharm Sci. 2022 Apr;111(4):919-932. doi: 10.1016/j.xphs.2021.12.002. Epub 2021 Dec 6. J Pharm Sci. 2022. PMID: 34883096 Review.

10

Stress Factors in Protein Drug Product Manufacturing and Their Impact on Product Quality.

Das TK, Sreedhara A, Colandene JD, Chou DK, Filipe V, Grapentin C, Searles J, Christian TR, Narhi LO, Jiskoot W. Das TK, et al. Among authors: chou dk. J Pharm Sci. 2022 Apr;111(4):868-886. doi: 10.1016/j.xphs.2021.09.030. Epub 2021 Sep 24. J Pharm Sci. 2022. PMID: 34563537

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

47 results

Search Page